Jagsonpal Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/04/2026 ,inter alia, to consider and approve Pursuant to Regulation ....
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jagsonpal Pharmaceuticals Ltd has notified exchanges that its Board of Directors will meet on April 27, 2026. The meeting agenda includes approval of audited financial results for Q4 and the full year ended March 31, 2026. The Board will also consider recommending a dividend for FY2025-26. This is a standard regulatory intimation under SEBI listing norms and does not contain any financial data or decisions at this stage. Actual results and dividend details will be disclosed after the meeting concludes.
This is a routine pre-result filing with no immediate share price impact. Investors should monitor for the actual financial results and dividend announcement expected after April 27, 2026.